Skip to content

Comparison of the effect of different timing of misoprostol tablet administration on softening of uterine cervix during hysteroscopic procedure

Comparison of two different timings of vaginal misoprostol in cervical priming among women undergoing vaginoscopic hysteroscopy: A Randomised controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015430
Enrollment
140
Registered
2018-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Women more than 18years of age undergoing Vaginoscopic Hysteroscopy in JIPMER

Interventions

Intervention1: Group A (Short interval group): Misoprostol 200mcg vaginally, given 3hours prior to the hysteroscopy. Control Intervention1: Group B, (Long interval group): Misoprostol 200mcg vaginally

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women more than 18years Undergoing vaginoscopic hysteroscopy in WCH JIPMER

Exclusion criteria

Exclusion criteria: Cervical stenosis Previous LSCS Contraindications to misoprostol

Design outcomes

Primary

MeasureTime frame
1. Ease of entry into the cervix recorded on a 10-point visual analogue scale and 5-point Likert scale 2. Pain perception, recorded by 10-point visual analogue scale and 11 point Numerical Rating Scale. 3. Procedural time from introduction of scope through external cervical os to visualization of the uterine cavityTimepoint: Pain will be assessed at three time points (1) During the procedure (2) At the end of the procedure (3) 30 minutes after the completion of procedure. Ease of entry and procedural will be recorded at the of procedure.

Secondary

MeasureTime frame
Procedural time Occurrence of side effectsTimepoint: Procedural time Occurrence of side effects

Countries

India

Contacts

Public ContactDr Dilip Kumar Maurya

JIPMER

dilipkm2@gmail.com9442136037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026